Chronic myeloid leukemia, from pathophysiology to treatment-free remission: a narrative literature review

I Rinaldi, K Winston - Journal of Blood Medicine, 2023 - Taylor & Francis
Chronic myeloid leukemia (CML) is one of the most common leukemias occurring in the
adult population. The course of CML is divided into three phases: the chronic phase, the …

JNK signaling as a target for anticancer therapy

KS Abdelrahman, HA Hassan, SA Abdel-Aziz… - Pharmacological …, 2021 - Springer
The JNKs are members of mitogen-activated protein kinases (MAPK) which regulate many
physiological processes including inflammatory responses, macrophages, cell proliferation …

Anxiolytic Effect of Citrus aurantium L. on Patients with Chronic Myeloid Leukemia

FCF Pimenta, MF Alves, MBF Pimenta… - Phytotherapy …, 2016 - Wiley Online Library
The bone marrow aspiration procedure is used in hematological diseases and consists of a
painful, invasive procedure causing anxiety‐associated symptoms. The present study …

Medication-induced pulmonary injury: a scenario-and pattern-based approach to a perplexing problem

S Sridhar, JP Kanne, TS Henry, JW Revels… - Radiographics, 2022 - pubs.rsna.org
Medication-induced pulmonary injury (MIPI) is a complex medical condition that has become
increasingly common yet remains stubbornly difficult to diagnose. Diagnosis can be aided …

[HTML][HTML] The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia

M El-Tanani, H Nsairat, II Matalka, YF Lee… - … -Research and Practice, 2024 - Elsevier
Abstract Chronic Myeloid Leukemia (CML) is characterized by chromosomal aberrations
involving the fusion of the BCR and ABL genes on chromosome 22, resulting from a …

[HTML][HTML] Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens

F Fei, Y Yu, A Schmitt, MT Rojewski, B Chen… - Experimental …, 2008 - Elsevier
OBJECTIVE: To investigate the inhibitory effects of dasatinib on proliferation, function, and
signaling events on CD8+ T cells. MATERIALS AND METHODS: Carboxyfluorescein …

Metabolism in stem cell–driven leukemia: parallels between hematopoiesis and immunity

KM Rattigan, MM Zarou… - Blood, The Journal of the …, 2023 - ashpublications.org
Our understanding of cancer metabolism spans from its role in cellular energetics and
supplying the building blocks necessary for proliferation, to maintaining cellular redox and …

Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review

V Kumar, P Singh, SK Gupta, V Ali, M Verma - Molecular and Cellular …, 2022 - Springer
Abstract Imatinib, nilotinib, dasatinib, bosutinib, ponatinib, and asciminib are FDA-approved
tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML), each of which has a …

[HTML][HTML] Experiences of living with chronic myeloid leukaemia and adhering to tyrosine kinase inhibitors: a thematic synthesis of qualitative studies

A Hewison, K Atkin, D McCaughan, E Roman… - European journal of …, 2020 - Elsevier
Purpose To investigate the experiences of adults living with chronic myeloid leukaemia and
treated with tyrosine kinase inhibitors, with particular reference to factors influencing …

Quercetin promotes cell cycle arrest and apoptosis and attenuates the proliferation of human chronic myeloid leukemia cell line-K562 through interaction with HSPs …

A Hassanzadeh, E Hosseinzadeh… - Anti-Cancer Agents …, 2019 - ingentaconnect.com
Background: Chronic Myeloid Leukaemia (CML) starts in certain blood-forming cells of the
bone marrow when cells acquire Philadelphia chromosome. Nowadays, scientists attempt to …